trademan1
Long

SPHS Oversold, Filling the Gap, cash/share > share price

NASDAQ:SPHS   SOPHIRIS BIO INC
Sophiris Bio             had a Phase III             drug trial test showing the drug was not effective and the market overreacted. The chart has a cash/share value (mrq) of $1.74, the float is 16.78 Million Shares (note today's volume alone is a large part of that), so with a tiny float, more cash per share on hand than the market price, and upcoming results for new Phase III             results for other products, one can see why people are buying this up right now.
KevinTang
6 months ago
new Phase III data for what products? and when
Reply
KevinTang KevinTang
6 months ago
sorry, wrong post.
Reply
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out